{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:09:10Z","timestamp":1762866550010,"version":"3.40.5"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004324","name":"Astellas Pharma Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.neuroscience.2014.12.065","type":"journal-article","created":{"date-parts":[[2015,1,14]],"date-time":"2015-01-14T05:54:17Z","timestamp":1421214857000},"page":"262-269","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Relationship between serotonin transporter occupancies and analgesic effects of AS1069562, the (+)-isomer of indeloxazine, and duloxetine in reserpine-induced myalgia rats"],"prefix":"10.1016","volume":"289","author":[{"given":"N.","family":"Murai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4092-2483","authenticated-orcid":false,"given":"H.","family":"Fushiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Iwashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Irie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Nagakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2014.12.065_b0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pain.2005.06.031","article-title":"A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder","volume":"119","author":"Arnold","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0010","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.psyneuen.2011.04.012","article-title":"Curcumin ameliorates reserpine-induced pain-depression dyad: behavioural, biochemical, neurochemical and molecular evidences","volume":"36","author":"Arora","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0015","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/archinte.163.20.2433","article-title":"Depression and pain comorbidity: a literature review","volume":"163","author":"Bair","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.ne.07.030184.001521","article-title":"Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry","volume":"7","author":"Basbaum","year":"1984","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0025","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s11916-013-0358-3","article-title":"Fibromyalgia comorbid with anxiety disorders and depression: combined medical and psychological treatment","volume":"17","author":"Bernik","year":"2013","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0030","first-page":"6","article-title":"Pathophysiologic mechanisms of fibromyalgia and its related disorders","volume":"69","author":"Bradley","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0035","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2174\/138920111798357258","article-title":"Fibromyalgia: mechanisms, current treatment and animal models","volume":"12","author":"Brederson","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0040","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1017\/S0140525X97251484","article-title":"Peripheral and central hyperexcitability: differential signs and symptoms in persistent pain","volume":"20","author":"Coderre","year":"1997","journal-title":"Behav Brain Sci"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0045","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4088\/JCP.v63n0407","article-title":"Duloxetine, 60mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial","volume":"63","author":"Detke","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0050","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pnpbp.2003.11.018","article-title":"Central monoamines and their role in major depression","volume":"28","author":"Elhwuegi","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0055","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/ar4441","article-title":"Review of pharmacological therapies in fibromyalgia syndrome","volume":"16","author":"Hauser","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0060","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.pbb.2008.08.029","article-title":"Intracerebroventricular fluvoxamine administration inhibited pain behavior but increased Fos expression in affective pain pathways","volume":"91","author":"Hayashi","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2014.05.043","article-title":"Effects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in mice","volume":"86","author":"Klein","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0070","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.neuroimage.2010.09.010","article-title":"Serotonin transporter binding in the hypothalamus correlates negatively with tonic heat pain ratings in healthy subjects: a [11C]DASB PET study","volume":"54","author":"Kupers","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0075","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/rheumatology\/40.3.290","article-title":"Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome","volume":"40","author":"Legangneux","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0080","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1124\/jpet.113.208686","article-title":"AS1069562, the (+)-isomer of indeloxazine, exerts analgesic effects in a rat model of neuropathic pain with unique characteristics in spinal monoamine turnover","volume":"348","author":"Murai","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuropharm.2013.10.030","article-title":"AS1069562, the (+)-isomer of indeloxazine, but not duloxetine has a curative-like analgesic effect in a rat model of streptozotocin-induced diabetic neuropathy","volume":"79","author":"Murai","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0090","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2014.03.038","article-title":"Antinociceptive effects of AS1069562, the (+)-isomer of indeloxazine, on spinal hypersensitivity induced by intrathecal injection of prostaglandin in mice: comparison with duloxetine and amitriptyline","volume":"733","author":"Murai","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0095","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2009.05.024","article-title":"Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: a putative animal model of fibromyalgia","volume":"146","author":"Nagakura","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0100","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.neuroscience.2010.06.061","article-title":"Reserpine causes biphasic nociceptive sensitivity alteration in conjunction with brain biogenic amine tones in rats","volume":"169","author":"Oe","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0105","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1002\/1529-0131(199911)42:11<2482::AID-ANR27>3.0.CO;2-B","article-title":"Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region","volume":"42","author":"Offenbaecher","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0110","first-page":"1","article-title":"Occupancy of serotonin transporter by tramadol: a positron emission tomography study with [11C]DASB","author":"Ogawa","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40122-013-0016-9","article-title":"Management of fibromyalgia syndrome: review of evidence","volume":"2","author":"Okifuji","year":"2013","journal-title":"Pain Ther"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0120","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/art.1780350509","article-title":"Cerebrospinal fluid biogenic amine metabolites in fibromyalgia\/fibrositis syndrome and rheumatoid arthritis","volume":"35","author":"Russell","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0125","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0304-3959(03)00115-5","article-title":"Intramuscular injection of tumor necrosis factor-alpha induces muscle hyperalgesia in rats","volume":"104","author":"Sch\u00e4fers","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0130","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ana.24065","article-title":"Hyperexcitable C nociceptors in fibromyalgia","volume":"75","author":"Serra","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0135","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0091-3057(93)90248-R","article-title":"Central activating properties of indeloxazine HCl and its optical isomers","volume":"45","author":"Shimizu-Sasamata","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0140","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1586\/ern.12.41","article-title":"Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions","volume":"12","author":"Staud","year":"2012","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0145","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00213-005-0304-0","article-title":"A dose-finding study of duloxetine based on serotonin transporter occupancy","volume":"185","author":"Takano","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0150","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1742-1241.2007.01433.x","article-title":"Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine","volume":"61","author":"Thor","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0155","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1021\/jm000079i","article-title":"Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio) araalkylamines","volume":"43","author":"Wilson","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0160","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/(SICI)1099-1344(19991230)42:13<1277::AID-JLCR284>3.0.CO;2-Q","article-title":"Radiosynthesis of carbon-11 labelled N-methyl-2-(arylthio)benzylamines: potential radiotracers for the serotonin reuptake receptor","volume":"42","author":"Wilson","year":"1999","journal-title":"J Labelled Comp Radiopharm"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0165","first-page":"555","article-title":"Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population","volume":"24","author":"Wolfe","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0170","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1586\/14737175.8.5.781","article-title":"Role of central dopamine in pain and analgesia","volume":"8","author":"Wood","year":"2008","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0175","first-page":"130","article-title":"Pharmacological and biochemical properties of indeloxazine hydrochloride, a new cerebral activator","volume":"3","author":"Yamamoto","year":"1990","journal-title":"Brain Dysfunct"},{"key":"10.1016\/j.neuroscience.2014.12.065_b0180","first-page":"90","article-title":"Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study","volume":"19","author":"Yunus","year":"1992","journal-title":"J Rheumatol"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452215000391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452215000391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T21:00:11Z","timestamp":1589490011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452215000391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":36,"alternative-id":["S0306452215000391"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2014.12.065","relation":{},"ISSN":["0306-4522"],"issn-type":[{"type":"print","value":"0306-4522"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}